A Phase II Study of Ofatumumab in Combination With High-dose Methylprednisolone in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL).
Phase of Trial: Phase II
Latest Information Update: 05 May 2017
At a glance
- Drugs Ofatumumab (Primary) ; Methylprednisolone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 14 Sep 2010 New source identified and integrated (Moores UCSD Cancer Center record 7012).
- 08 Sep 2010 New trial record